T-cell receptor on CD4+ helper T cells specific for SARS-CoV-2 spike protein (Spike-specific CD4+ TCR)

The T-cell receptor (TCR) on CD4+ helper T cells specific for SARS-CoV-2 spike protein is a heterodimeric surface protein complex responsible for recognizing viral antigens. This receptor identifies specific peptide fragments derived from the spike protein that are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (Grifoni et al., 2020, Cell). Upon recognition, the TCR triggers a signaling cascade through the CD3 complex, leading to the activation, proliferation, and differentiation of CD4+ T cells into effector subsets like Th1 and T follicular helper (Tfh) cells (Sette & Crotty, 2021, Cell). These cells play a pivotal role in the immune response by secreting cytokines such as interferon-gamma and providing essential help to B cells for high-affinity antibody production. This TCR is the primary target of COVID-19 vaccines, including mRNA and viral vector platforms, which aim to establish long-term T-cell memory (Sahin et al., 2020, Nature). Additionally, it is a focus for therapeutic interventions such as TCR-engineered T-cell (TCR-T) therapies designed to treat severe or chronic COVID-19 (Low et al., 2021, Antiviral Research). Monitoring the activity and repertoire of these TCRs serves as a critical biomarker for assessing vaccine efficacy and natural immunity.

Other names

SARS-CoV-2 spike-reactive T-cell receptorSpike-specific TCRCD4+ TCR recognizing spike peptidesMHC-II restricted spike TCR

The TCR recognizes specific spike-derived peptides presented by MHC class II molecules on antigen-presenting cells, triggering a signaling cascade that leads to CD4+ T-cell activation, proliferation, and the secretion of cytokines (e.g., IFN-gamma, IL-2) to coordinate the adaptive immune response.